Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HEATR6 divergent transcript (HEATR6-DT) is a long non-coding RNA (lncRNA), transcribed from the region adjacent to the HEATR6 gene but does not encode a protein. Its exact biological function is not well understood, and there are currently no reported roles as a therapeutic target or validated disease biomarker. Recent transcriptomics studies have noted changes in its expression levels in certain disease states (such as chronic actinic rhinitis and aspirin-exacerbated respiratory disease), but its functional significance and molecular mechanisms remain uncharacterized. There are no known drugs or therapies that interact with HEATR6-DT, nor is it classified within established receptor, enzyme, transporter, or transcription factor families. The gene is correctly named, and information is appropriately limited by the current state of research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HEATR6 divergent transcript (HEATR6-DT).